Cancer Therapies & Ablation

Clinical Data

Interventional Oncology / Cancer Therapies & Ablation / Clinical Data

No one is investing in Interventional Oncology like Boston Scientific

Last year, over 1 million patients were impacted by Boston Scientific interventional oncology products - 46,000 cancer patients were treated with a Boston Scientific cancer therapy. Our goal is to advance the interventional radiology specialty and support you with the best products, technologies and data.

50 investigator-initiated studies graphic.

Global Interventional Oncology investigator-initiated studies

Patients enrolled in Interventional Oncology clinical trials

60m IO R&D and clinical initiatives graphic.

Invested in Interventional Oncology R&D and clinical initiatives

Physician-Initiated Research

Boston Scientific has invested heavily in physician-initiated research, partnering with interventionalists to help advance the field of interventional oncology, expanded applications, and the use of combination therapies.

Key strategic areas of interest include:

Assessing the synergistic effects of combining locoregional therapy with immunotherapies
Exploring the safety and efficacy of our treatments being used in expanded ways (often leading to the pursuit of new indications)
Studies that explore improvements in techniques and clinical outcomes (think patient selection optimization, advancing dosimetry techniques)